Q-3 fatty acid supplement use in the 45 and Up Study Cohort

Adams, J; Sibbritt, D; Lui, CW; Broom, A; Wardle, J

Q-3 fatty acid supplement use in the 45 and Up Study Cohort

Adams, J

Sibbritt, D

Lui, CW Broom, A

Wardle, J

Permalink

Publication Type:: Journal Article
Citation:: BMJ Open, 2013, 3 (4)
Issue Date:: 2013-05-16

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Accepted Manuscript VersionAdobe PDF (169.41 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.contributor.author	Sibbritt, D https://orcid.org/0000-0003-3561-9447	en_US
dc.contributor.author	Lui, CW	en_US
dc.contributor.author	Broom, A https://orcid.org/0000-0003-1258-1140	en_US
dc.contributor.author	Wardle, J https://orcid.org/0000-0001-8813-3542	en_US
dc.date.issued	2013-05-16	en_US
dc.identifier.citation	BMJ Open, 2013, 3 (4)	en_US
dc.identifier.uri	http://hdl.handle.net/10453/37264
dc.description.abstract	Objective: There has been a dramatic increase in the use of dietary supplements in Western societies over the past decades. Our understanding of the prevalence of Q-3 fatty acid supplement consumption is of significance for future nutrition planning, health promotion and care delivery. However, we know little about Q-3 fatty acid supplement consumption or users. This paper, drawing upon the largest dataset with regard to Q-3 fatty acid supplement use (n=266 848), examines the use and users of this supplement among a large sample of older Australians living in New South Wales. Design: A cross-sectional study. Data were analysed from the 45 and Up Study, the largest study of healthy ageing ever undertaken in the Southern Hemisphere. Setting: New South Wales, Australia. Participants: 266 848 participants of the 45 and Up Study. Primary and secondary outcome measures: Participants' use of Q-3, demographics (geographical location, marital status, education level, income and level of healthcare insurance) and health status (quality of life, history of smoking and alcohol consumption, health conditions) were measured. Results: Of the 266 848 participants, 32.6% reported having taken Q-3 in the 4 weeks prior to the survey. Use of Q-3 fatty acid supplements was higher among men, non-smokers, non-to-mild (alcoholic) drinkers, residing in a major city, having higher income and private health insurance. Osteoarthritis, osteoporosis, high cholesterol and anxiety and/or depression were positively associated with Q-3 fatty acid supplement use, while cancer and high blood pressure were negatively associated with use of Q-3 fatty acid supplements. Conclusions: This study, analysing data from the 45 and Up Study cohort, suggests that a considerable proportion of older Australians consume Q-3 fatty acid supplements. There is a need for primary healthcare practitioners to enquire with patients about this supplement use and for work to ensure provision of good-quality information for patients and providers with regard to Q-3 fatty acid products.	en_US
dc.relation.ispartof	BMJ Open	en_US
dc.relation.isbasedon	10.1136/bmjopen-2012-002292	en_US
dc.title	Q-3 fatty acid supplement use in the 45 and Up Study Cohort	en_US
dc.type	Journal Article
utslib.citation.volume	4	en_US
utslib.citation.volume	3	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	1103 Clinical Sciences	en_US
utslib.for	1199 Other Medical and Health Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	open_access
pubs.issue	4	en_US
pubs.publication-status	Published	en_US
pubs.volume	3	en_US

Abstract:

Objective: There has been a dramatic increase in the use of dietary supplements in Western societies over the past decades. Our understanding of the prevalence of Q-3 fatty acid supplement consumption is of significance for future nutrition planning, health promotion and care delivery. However, we know little about Q-3 fatty acid supplement consumption or users. This paper, drawing upon the largest dataset with regard to Q-3 fatty acid supplement use (n=266 848), examines the use and users of this supplement among a large sample of older Australians living in New South Wales. Design: A cross-sectional study. Data were analysed from the 45 and Up Study, the largest study of healthy ageing ever undertaken in the Southern Hemisphere. Setting: New South Wales, Australia. Participants: 266 848 participants of the 45 and Up Study. Primary and secondary outcome measures: Participants' use of Q-3, demographics (geographical location, marital status, education level, income and level of healthcare insurance) and health status (quality of life, history of smoking and alcohol consumption, health conditions) were measured. Results: Of the 266 848 participants, 32.6% reported having taken Q-3 in the 4 weeks prior to the survey. Use of Q-3 fatty acid supplements was higher among men, non-smokers, non-to-mild (alcoholic) drinkers, residing in a major city, having higher income and private health insurance. Osteoarthritis, osteoporosis, high cholesterol and anxiety and/or depression were positively associated with Q-3 fatty acid supplement use, while cancer and high blood pressure were negatively associated with use of Q-3 fatty acid supplements. Conclusions: This study, analysing data from the 45 and Up Study cohort, suggests that a considerable proportion of older Australians consume Q-3 fatty acid supplements. There is a need for primary healthcare practitioners to enquire with patients about this supplement use and for work to ensure provision of good-quality information for patients and providers with regard to Q-3 fatty acid products.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/37264